Image Not FoundImage Not Found

Emerging

Testosterone Therapy Risks and Misuse: Why 88% of Men May Be Inappropriately Treated Despite Rising TRT Popularity

Analysis of the U.S. testosterone replacement therapy (TRT) surge reveals a fourfold increase in use despite only 12%…

ByByAarav Patel Jun 15, 2026

Base Editing Human Embryos: Ethical Risks and Scientific Advances in Safer Gene Editing Techniques

This briefing analyzes Columbia University’s base editing of human zygotes targeting cholesterol and hemoglobin loci, highlighting technical challenges…

ByByJuan Martinez Jun 14, 2026

First Confirmed Death by Fully Autonomous AI Drone in Russo-Ukrainian War Sparks Ethical and Military Concerns

The briefing analyzes the operational deployment of fully autonomous lethal drones, emphasizing onboard AI-driven target detection and engagement…

ByByOlivia Wilson Jun 14, 2026

GM to Launch Eyes-Off Highway Driving by 2028 with Cadillac Escalade IQ, Pivoting from Cruise Robotaxi to Advanced Personal Autonomy

General Motors is refocusing its autonomy strategy on delivering eyes-off highway driving by 2028 via the Cadillac Escalade…

ByByJuan Martinez Jun 14, 2026
Image Not Found

SpaceX Stock Plummets to $115 Amid $1.1 Trillion Market Cap Loss, Starship Launch Failures, and Tesla Merger Speculation

Analysis of SpaceX’s post-IPO valuation decline amid Starship’s Raptor engine ignition failures highlights investor focus on engineering reliability,…

ByByLiam Brown Jul 23, 2026

Neuralink Valued Up to $42B Amid Soaring Investor Demand Fueled by Elon Musk’s SpaceX Success

Neuralink’s secondary-market valuation surge reflects capital psychology amid limited clinical validation of its ultra-high-bandwidth, minimally invasive brain-computer interfaces.…

ByByLiam Brown Jul 23, 2026